Research Library
EARLY TRANSLATIONAL

CJC-1295 (No DAC)

Also known as: Mod GRF 1-29, Modified GRF

Growth Factor ResearchPeptide Signaling
ClassificationSynthetic 29-amino-acid analog of growth-hormone-releasing hormone (GHRH 1-29) with stabilizing substitutions.
TargetsGHRH receptor biology; Somatotroph signaling models

Molecular Overview

CJC-1295 without DAC (Mod GRF 1-29) is a modified GHRH fragment studied for its interaction with GHRH-receptor signaling in experimental settings.

Mechanistic Background

Amino-acid substitutions are designed to resist enzymatic degradation relative to native GHRH 1-29.

What Researchers Study

Characterized in receptor-signaling and secretagogue research models.

Evidence Landscape

Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Limited controlled human data for this specific analog; commercial material may differ from published preparations.

Documentation

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.